Tachykinins and their receptors in human malignancies

Carla Palma1

  • 1Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy. c.palma@iss.it

Current Drug Targets
|August 22, 2006
PubMed

Insights

Neuropeptides called tachykinins and their receptors are implicated in cancer development and spread. Further research is needed to fully define their role and potential as cancer drug targets.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Tachykinins are neuropeptides that regulate physiological functions and are involved in pathological conditions, including cancer.
  • Tachykinins and their receptors (NK1, NK2, NK3) are expressed in both neuronal and non-neuronal cells, highlighting their systemic influence.
  • Their involvement in processes like cell proliferation, survival, and immune response suggests a role in carcinogenesis.

Purpose of the Study:

  • To explore the multifaceted roles of tachykinins in various stages of cancer development and progression.
  • To investigate how tachykinins and their receptors contribute to tumor growth, metastasis, and associated symptoms.
  • To assess the potential of targeting tachykinin signaling pathways for cancer therapy.

Main Methods:

  • Review and synthesis of existing scientific literature on tachykinins, their receptors, and their involvement in cancer.
  • Analysis of studies examining tachykinin expression in different cancer types (e.g., astrocytoma, neuroblastoma, breast cancer).
  • Examination of evidence linking tachykinin signaling to cancer cell proliferation, survival, metastasis, and tumor microenvironment modulation.

Main Results:

  • Tachykinins can promote cancer cell proliferation and survival by hijacking normal signaling pathways in tumors expressing NK receptors.
  • They facilitate tumor metastasis, particularly in bone marrow, and contribute to symptoms in neuroendocrine carcinomas.
  • Tachykinins influence angiogenesis and immunosuppression, potentially increasing cancer incidence and progression.

Conclusions:

  • Tachykinins play a significant role in multiple aspects of cancer, from initiation to metastatic spread.
  • Their involvement in tumor growth, symptom manifestation, and immune modulation underscores their complex contribution to cancer pathology.
  • While promising as therapeutic targets, the precise mechanisms and clinical efficacy require further comprehensive investigation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...